0001486189-23-000035.txt : 20231004 0001486189-23-000035.hdr.sgml : 20231004 20231004121542 ACCESSION NUMBER: 0001486189-23-000035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20231004 DATE AS OF CHANGE: 20231004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lau Stanley K. CENTRAL INDEX KEY: 0001950824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41097 FILM NUMBER: 231307213 MAIL ADDRESS: STREET 1: C/O CARDIO DIAGNOSTICS HOLDINGS INC. STREET 2: 400 N. ABERDEEN ST., SUITE 900 CITY: CHICAGO STATE: IL ZIP: 60642 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardio Diagnostics Holdings, Inc. CENTRAL INDEX KEY: 0001870144 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870925574 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 311 W. SUPERIOR STREET STREET 2: SUITE 444 CITY: CHICAGO STATE: IL ZIP: 60645 BUSINESS PHONE: 855-226-9991 MAIL ADDRESS: STREET 1: 311 W. SUPERIOR STREET STREET 2: SUITE 444 CITY: CHICAGO STATE: IL ZIP: 60645 FORMER COMPANY: FORMER CONFORMED NAME: Mana Capital Acquisition Corp. DATE OF NAME CHANGE: 20210629 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-07-31 0 0001870144 Cardio Diagnostics Holdings, Inc. CDIO 0001950824 Lau Stanley K. C/O CARDIO DIAGNOSTICS HOLDINGS INC. 311 W. SUPERIOR ST. SUITE 444 CHICAGO IL 60654 1 0 0 0 0 Common Stock 2023-07-31 4 M 0 1653 1.21 A 31064 D Common Stock 2023-08-31 4 M 0 3637 0.5499 A 34701 D Common Stock 2023-09-30 4 M 0 5882 0.34 A 40583 D Common Stock 2023-09-30 4 M 0 36765 0.34 A 77348 D Restricted Stock Units 0 2023-07-31 4 M 0 2000 0 D 2023-07-31 2024-01-31 Common Stock 2000 12000 D Restricted Stock Units 0 2023-08-31 4 M 0 2000 0 D 2023-08-31 2024-01-31 Common Stock 2000 10000 D Restricted Stock Units 0 2023-09-30 4 M 0 2000 0 D 2023-09-30 2024-01-31 Common Stock 2000 8000 D Restricted Stock Units 0 2023-09-30 4 M 0 12500 0 D 2023-09-30 2023-12-31 Common Stock 12500 12500 D Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on July 31, 2023 through the issuance of shares of Common Stock. Represents the settlement of RSUs, awarded for advisory services, which vested on August 31, 2023 through the issuance of shares of Common Stock Represents the settlement of RSUs, awarded for advisory services, which vested on September 30, 2023 through the issuance of shares of Common Stock. Represents the settlement of RSUs, awarded as director compensation, which vested on September 30, 2023 through the issuance of shares of Common Stock. Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On July 31, 2023, $2,000 in value of RSUs vested and were settled at the price of $1.21, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I. On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024. The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On August 31, 2023, $2,000 in value of RSUs vested and were settled at the price of $0.5499, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I. Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $2,000 in value of RSUs vested and were settled at the price of $0.34 which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I. Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34 which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I. On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date. /s/ Elisa Luqman as attorney-in-fact for Stanley Lau 2023-10-04